Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer

por Leitch, E F, Chakrabarti, M, Crozier, J E M, McKee, R F, Anderson, J H, Horgan, P G, McMillan, D C
Publicado 2007

Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linke...

por Cummings, J, Ranson, M, LaCasse, E, Ganganagari, J R, St-Jean, M, Jayson, G, Durkin, J, Dive, C
Publicado 2006

Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer

por Griebsch, I, Brown, J, Boggis, C, Dixon, A, Dixon, M, Easton, D, Eeles, R, Evans, D G, Gilbert, F J, Hawnaur, J, Kessar, P, Lakhani, S R, Moss, S M, Nerurkar, A, Padhani, A R, Pointon, L J, Potterton, J, Thompson, D, Turnbull, L W, Walker, L G, Warren, R, Leach, M O
Publicado 2006

Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer

por von Plessen, C, Bergman, B, Andresen, O, Bremnes, R M, Sundstrom, S, Gilleryd, M, Stephens, R, Vilsvik, J, Aasebo, U, Sorenson, S
Publicado 2006

SCOTROC 2A: Carboplatin followed by docetaxel or docetaxel–gemcitabine as first-line chemotherapy for ovarian cancer

por Vasey, P A, Atkinson, R, Osborne, R, Parkin, D, Symonds, R, Paul, J, Lewsley, L, Coleman, R, Reed, N S, Kaye, S, Rustin, G J S
Publicado 2006

A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen

por Culine, S, Theodore, C, De Santis, M, Bui, B, Demkow, T, Lorenz, J, Rolland, F, Delgado, F-M, Longerey, B, James, N
Publicado 2006

Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis

por Pearce, C L, Wu, A H, Gayther, S A, Bale, A E, Beck, P A, Beesley, J, Chanock, S, Cramer, D W, DiCioccio, R, Edwards, R, Fredericksen, Z S, Garcia-Closas, M, Goode, E L, Green, A C, Hartmann, L C, Hogdall, E, Kjær, S K, Lissowska, J, McGuire, V, Modugno, F, Moysich, K, Ness, R B, Ramus, S J, Risch, H A, Sellers, T A, Song, H, Stram, D O, Terry, K L, Webb, P M, Whiteman, D C, Whittemore, A S, Zheng, W, Pharoah, P D P, Chenevix-Trench, G, Pike, M C, Schildkraut, J, Berchuck, A
Publicado 2008

Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer

por Lin, H-J, Hsieh, F-C, Song, H, Lin, J
Publicado 2005

Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures

por Apolone, G, Joppi, R, Bertele', V, Garattini, S
Publicado 2005

Array comparative genomic hybridisation (aCGH) analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from Western New York

por Varma, G, Varma, R, Huang, H, Pryshchepava, A, Groth, J, Fleming, D, Nowak, N J, McQuaid, D, Conroy, J, Mahoney, M, Moysich, K, Falkner, K L, Geradts, J
Publicado 2005

An immunohistochemical perspective of PPARβ and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours

por Ahmed, N, Riley, C, Quinn, M A
Publicado 2008

Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bispho...

por Wardley, A, Davidson, N, Barrett-Lee, P, Hong, A, Mansi, J, Dodwell, D, Murphy, R, Mason, T, Cameron, D
Publicado 2005

Inflammation-associated gene expression is altered between normal human ovarian surface epithelial cells and cell lines derived from ovarian adenocarcinomas

por Gubbay, O, Guo, W, Rae, M T, Niven, D, Langdon, S P, Hillier, S G
Publicado 2005

Years of life lost (YLL) from cancer is an important measure of population burden – and should be considered when allocating research funds

por Burnet, N G, Jefferies, S J, Benson, R J, Hunt, D P, Treasure, F P
Publicado 2005

Investigation of systemic folate status, impact of alcohol intake and levels of DNA damage in mononuclear cells of breast cancer patients

por Hussien, M M I, McNulty, H, Armstrong, N, Johnston, P G, Spence, R A J, Barnett, Y
Publicado 2005

Phase I and pharmacokinetic study of the novel chemoprotector BNP7787 in combination with cisplatin and attempt to eliminate the hydration schedule

por Boven, E, Westerman, M, van Groeningen, C J, Verschraagen, M, Ruijter, R, Zegers, I, van der Vijgh, W J F, Giaccone, G
Publicado 2005

Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topography

por Nakase, Y, Sakakura, C, Miyagawa, K, Kin, S, Fukuda, K, Yanagisawa, A, Koide, K, Morofuji, N, Hosokawa, Y, Shimomura, K, Katsura, K, Hagiwara, A, Yamagishi, H, Ito, K, Ito, Y
Publicado 2005

Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma

por Uchida, S, Shimada, Y, Watanabe, G, Li, Z Gang, Hong, T, Miyake, M, Imamura, M
Publicado 1999

Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR

por de Vries, T J, Fourkour, A, Punt, C J A, van de Locht, L T F, Wobbes, T, Bosch, S van den, Rooij, M J M de, Mensink, E J B M, Ruiter, D J, Muijen, G N P van
Publicado 1999

Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone versus immunochemotherapy for malignant effus...

por Nio, Y, Nagami, H, Tamura, K, Tsubono, M, Nio, M, Sato, M, Kawabata, K, Hayashi, H, Shiraishi, T, Imai, S, Tsuchitani, T, Mizuta, J, Nakagawa, M, Fukumoto, M
Publicado 1999